TASE advances despite Teva decline

The market rose slightly today, not helped by Teva, as investors continue to absorb the upheavals at the company, but another drug company, Perrigo, advanced strongly.

By AVIV LEVY, GLOBES' CORRESPONDENT
November 1, 2013 03:57
Tel Aviv Stock Exchange

Tel Aviv Stock Exchange TASE 58 (R). (photo credit: Gil Cohen Magen / Reuters)

1


Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS